Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
alveolar epithelial cells. The project will aim to identify and study the lipids transported and the proteins involved in this pathway, and to decipher their functional implications in surfactant lipid
-
Skills (30%) a. Model-Driven Optimization: Use simulation and digital twin outputs to analyze process parameters, predict cell behavior, and guide the design of optimized cell culture protocols and next
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 14 days ago
regulation and lymphoma pathogenesis, has emerged as a promising candidate. We showed that PSGL-1 blockade with a monoclonal antibody (mAb) enhances T cell activation, alters the lymphoma immune
-
available in the Pan Hammarström Lab (https://ki.se/en/research/groups/pan-hammarstrom-lab ), which is part of the Division of Immunology under the Department of Medical Biochemistry and Biophysics
-
position within a Research Infrastructure? No Offer Description JOB REFERENCE: PA260302 Full-time academic position Faculty of Sciences Field: Animal cell Biology Start date: 01/09/2026 The University
-
, and cell biology. Job description Design, implement, optimize, and maintain automated laboratory workflows for life science applications Provide expert support for laboratory automation platforms (e.g
-
Department: Tomáš Bárta Research Group: Stem Cell Biology and Vision Research – Faculty of Medicine Deadline: 31 Jan 2026 Start date: April 2026 or upon agreement Job type: full-time Job field
-
laboratory. The candidate will benefit from the expertise in numerical simulation and bioinformatics available at the L2C and the IBMM. The IBMM will produce the initial glycoproteins for calculations using
-
to the development of large-scale bone tissue implants. Beyond a certain size, sufficient vascularization of the implant is essential to enable the formation of functional bone tissue and to reduce cell necrosis
-
tumour cells (CTCs), cancer cell free-mRNA and DNA from blood, offer a minimally invasive approach for early diagnosis and disease monitoring cancer progression and treatment response. However, the current